Qingdao Vland Biotech INC. (SHA:603739)
China · Delayed Price · Currency is CNY 15.64
+0.01 (0.06%)
At close: Feb 13, 2026
SHA:603739 Market Cap
SHA:603739 has a market cap or net worth of 3.96 billion as of February 13, 2026. Its market cap has increased by 33.45% in one year.
Market Cap
3.96B
Enterprise Value
4.33B
Revenue
1.39B
Ranking
n/a
PE Ratio
47.19
Stock Price
15.64
Market Cap Chart
Since January 16, 2019, SHA:603739's market cap has increased from 2.27B to 3.96B, an increase of 74.41%. That is a compound annual growth rate of 8.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 3.96B | 10.53% |
| Dec 31, 2025 | 3.58B | 18.02% |
| Dec 31, 2024 | 3.03B | -21.22% |
| Dec 29, 2023 | 3.85B | 13.69% |
| Dec 30, 2022 | 3.39B | -27.76% |
| Dec 31, 2021 | 4.69B | 34.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Obio Technology (Shanghai) Corp. | 4.47B |
| Hinova Pharmaceuticals | 4.47B |
| Guanhao Biotech | 4.15B |
| Zhejiang Wecome Pharmaceutical Company | 4.12B |
| Zhejiang Shouxiangu Pharmaceutical | 4.10B |
| Boji Medical Technology | 4.05B |
| Shenzhen Bioeasy Biotechnology | 3.97B |
| Shanghai Shen Lian Biomedical | 3.97B |